Target Name: SLAIN1
NCBI ID: G122060
Other Name(s): SLAIN motif-containing protein 1 (isoform A) | C13orf32 | FLJ30046 | SLAIN motif-containing protein 1 | SLAIN motif-containing protein 1 (isoform B) | SLAIN1 variant 1 | SLAIN motif-containing protein 1 (isoform C) | SLAIN motif family, member 1, transcript variant 3 | SLAIN motif family member 1, transcript variant 2 | SLAIN motif family member 1 | SLAIN1 variant 3 | SLAIN1 variant 2 | SLAIN motif family member 1, transcript variant 1 | SLAI1_HUMAN | SLAIN motif-containing protein 1 precursor

SLAIN1: A Potential Drug Target and Biomarker for glial cells in neurodegenerative Disorders

Glial cells, which are the supportive cells of nerve fibers, are crucial for maintaining the integrity of neural circuits. In neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, glial cells are often affected, leading to disruptions in neural circuits and progressive neurodegeneration. SLAIN1, a protein that contains the SLAIN motif, has been identified as a potential drug target and biomarker for these disorders. In this article, we will discuss the SLAIN1 protein, its functions in glial cells, and its potential as a drug target in neurodegenerative disorders.

SLAIN1: Background and Characteristics

SLAIN1 is a protein that was first identified in the brain using transcriptomics techniques. It is a 21-kDa protein that contains the SLAIN motif, which is a unique protein-protein interaction that is involved in the regulation of protein stability and localization. The SLAIN motif is composed of three domains: N-terminal, C-terminal, and R-terminal.

The N-terminal domain of SLAIN1 contains a unique fusion of the amino acids Asp, Asn, and Asp at its N-terminus. This fusion is thought to play a role in the stability of the protein and its ability to localize to specific cellular compartments. The C-terminal domain of SLAIN1 contains a conserved structural core that is involved in the formation of a hydrophobic core. This core is thought to contribute to the stability of the protein and its ability to interact with other cellular components. The R-terminal domain of SLAIN1 contains a unique fusion of the amino acids Asp, Asn, Asp, and Asn at its R-terminus. This fusion is thought to play a role in the stability of the protein and its ability to localize to specific cellular compartments.

SLAIN1 functions in glial cells

GLIAL Cells:

Glial cells are the supportive cells of nerve fibers. They are responsible for maintaining the integrity of neural circuits, and for transmitting signals from the brain to the rest of the body. Glial cells are highly specialized cells that are involved in the regulation of neural circuits. They are able to detect changes in the environment and to respond accordingly.

SLAIN1 is involved in the regulation of the stability and localization of other proteins in glial cells. It is thought to play a role in the regulation of the stability of the GLT-1 protein, which is involved in the generation of action potentials in neural circuits. SLAIN1 is also thought to play a role in the regulation of the stability and localization of the neurotransmitter glutamate, which is involved in the regulation of neural circuits.

In addition to its role in regulating the stability and localization of other proteins, SLAIN1 is also involved in the regulation of its own stability. Studies have shown that SLAIN1 is involved in the regulation of its own stability by interacting with its own N-terminal domain. This interaction may play a role in the regulation of SLAIN1's stability and localization.

Potential as a Drug Target:

The regulation of SLAIN1 by its SLAIN motif suggests that it may be a potential drug target in neurodegenerative disorders. SLAIN1 has been shown to be involved in the regulation of cellular processes that are involved in the development and progression of neurodegenerative disorders. For example, SLAIN1 has been shown to play a role in the regulation of neurotransmitter homeostasis, which is important for the regulation of mood, anxiety, and other neurological disorders.

In addition to its role in the regulation of neurotransmitter homeostasis, SLAIN1 may also be involved in the regulation of

Protein Name: SLAIN Motif Family Member 1

Functions: Microtubule plus-end tracking protein that might be involved in the regulation of cytoplasmic microtubule dynamics, microtubule organization and microtubule elongation

More Common Targets

SLAIN2 | SLAM Family Member | SLAMF1 | SLAMF6 | SLAMF6P1 | SLAMF7 | SLAMF8 | SLAMF9 | SLBP | SLC corepressor complex | SLC10A1 | SLC10A2 | SLC10A3 | SLC10A4 | SLC10A5 | SLC10A6 | SLC10A7 | SLC11A1 | SLC11A2 | SLC12A1 | SLC12A2 | SLC12A2-DT | SLC12A3 | SLC12A4 | SLC12A5 | SLC12A5-AS1 | SLC12A6 | SLC12A7 | SLC12A8 | SLC12A9 | SLC13A1 | SLC13A2 | SLC13A3 | SLC13A4 | SLC13A5 | SLC14A1 | SLC14A2 | SLC15A1 | SLC15A2 | SLC15A3 | SLC15A4 | SLC15A5 | SLC16A1 | SLC16A10 | SLC16A11 | SLC16A12 | SLC16A13 | SLC16A14 | SLC16A2 | SLC16A3 | SLC16A4 | SLC16A5 | SLC16A6 | SLC16A6P1 | SLC16A7 | SLC16A8 | SLC16A9 | SLC17A1 | SLC17A2 | SLC17A3 | SLC17A4 | SLC17A5 | SLC17A6 | SLC17A7 | SLC17A8 | SLC17A9 | SLC18A1 | SLC18A2 | SLC18A3 | SLC18B1 | SLC19A1 | SLC19A2 | SLC19A3 | SLC1A1 | SLC1A2 | SLC1A3 | SLC1A4 | SLC1A5 | SLC1A6 | SLC1A7 | SLC20A1 | SLC20A1-DT | SLC20A2 | SLC22A1 | SLC22A10 | SLC22A11 | SLC22A12 | SLC22A13 | SLC22A14 | SLC22A15 | SLC22A16 | SLC22A17 | SLC22A18 | SLC22A18AS | SLC22A2 | SLC22A20P | SLC22A23 | SLC22A24 | SLC22A25 | SLC22A3